Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Down 168.60p
Change Today:
-0.40p
Market Cap:
1,124.11m
Sector:
Equity Investment Instruments

Achilles Therapeutics prices IPO at $175m as Syncona keeps 27% stake

By Frank Prenesti

Date: Wednesday 31 Mar 2021

LONDON (ShareCast) - (Sharecast News) - Syncona portfolio biopharma company Achilles Therapeutics said its US initial public offering (IPO) will raise $175.5m (127.8mln).
Achilles, which is developing precision T cell therapies to treat solid tumours, will place 9.7m American depositary shares (ADS) on the Nasdaq exchange at $18 each. Trading is expected to start on Wednesday.

Syncona said it would retain a 27% stake in Achilles worth 145.4mln after the float, a 50.6m rise in value since it first invested.

"Today's milestone is a significant achievement for Achilles as it seeks to deliver its ambition of bringing neo-antigen targeted T-cell therapies to cancer patients," said Syncona investment management chief executive Martin Murphy.

"It comes less than five years after Syncona's first investment at the foundation of the company and we look forward to seeing the company's continued progress."

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SYNC Market Data

Currency UK Pounds
Price 168.60p
Change Today -0.40p
52 Week High 278.50p
52 Week Low 163.40p
Volume 276,704
Shares Issued 666.73m
Market Cap 1,124.11m

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. half sector star
  4. empty sector
  5. empty sector
Price Trend
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. empty sector
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Income
Not Available
Growth
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. half sector star
  4. empty sector
  5. empty sector
Price Chg 6m
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. empty sector
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
P/E
Not Available
PEG
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Dividend Yield
Not Available
EPS Growth
Not Available
Operating Margin
market
  1. full market star
  2. full market star
  3. half market star
  4. empty market
  5. empty market
sector
  1. half sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SYNC Dividends

  Latest Previous
  Final Final
Ex-Div 21-Jun-18 20-Jul-17
Paid 30-Jul-18 23-Aug-17
Amount 2.30p 2.30p

Trades for 18-Oct-2021

Time Volume / Share Price
15:02 7,479 @ 168.34p
15:00 1,681 @ 168.60p
15:00 750 @ 168.60p
14:32 2,920 @ 168.11p
14:26 70 @ 168.12p

SYNC Key Personnel

Chair Melanie Gee